FdaApplication

NDA 202428

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMAYNE PHARMA LLC
application_typeNDA
approval_date2012-05-11

Products (1)

ProductActive ingredientStrengthDosage form
FABIORTAZAROTENE0.1%AEROSOL, FOAM;TOPICAL

1 product